Torque, an immuno-oncology company developing Deep Primed™ cellular therapies with pharmacologic control to direct immune power deep within the tumor microenvironment, announced today the appointment of Thomas Andresen, PhD, as Chief Scientific Officer.
April 10, 2018
· 3 min read